State Stem Cell Agency ICOC Agenda 11-02-05

Nov 2, 2005
Main Location: 

Moscone Center South
747 Howard St
Room 304
San Francisco, CA

 

 

 

 

 

 

 

 

 

California State Stem Cell Agency

 

Regular Meeting of the ICOC to the CIRM

INDEPENDENT CITIZENS' OVERSIGHT COMMITTEE ("ICOC")
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 

OPEN SESSION

MEETING STARTS AT 8:30 AM IN ROOM 303

  1. Call to Order.
  2. Spotlight Presentation on HIV/AIDS.

MOVE TO ROOM 304 at 9:30 AM (Estimated time)

  1. Pledge of Allegiance.
  2. Roll Call.

    [Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

 

CONSENT ITEMS

  1. Approval of minutes from September 9, 2005 ICOC meeting.
  2. Approval of Marcy Feit as ICOC patient advocate member on each of the three CIRM Working Groups in place of former ICOC patient advocate member Phyllis Preciado.
  3. Approval of revised CIRM Conflict of Interest Code.
      a. Key to COI Code Revision
 
REGULAR ITEMS
  1. Chairman's Report
  2. President's Report
  3. Consideration of formation of Strategic Planning Subcommittee.
  4. Consideration of report from IP Task Force Subcommittee.
  5. Consideration of report from Standards Working Group, including but not limited to:
      a. Consideration of CIRM interim guidelines for human embryonic stem cell research
      b. Consideration of Bylaws for Standards Working Group
      c. Consideration of Standards Working Group Meeting Procedures
      d. Consideration of recommended new members

CLOSED SESSION

 

  13.
           a.
Pending Litigation (Government Code section 11126, subdivision (e)): People's Advocate v. Independent Citizens' Oversight Committee, Alameda County Superior Court, Case No. HG05206766, consolidated with California Family Bioethics Council v. California Institute for Regenerative Medicine, Alameda County Superior Court, Case No. HG05235177; and Mary Scott Doe v. Robert Klein, et al., U.S. District Court, Central District, Case No. ED CV 05-00438.
           b. Discussion of Personnel (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(d)(3)(D)).
 

  1. Public report of any action taken, if necessary, during closed session.
  2. Consideration of report from Facilities Working Group.
  3. Consideration of interim grants administration policy for training grants.
  4. Consideration of interim criteria for review of research grant applications.
  5. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.
  6. Adjournment.

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

 

 


 

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.

 

Transcripts: 

© 2013 California Institute for Regenerative Medicine